REVIEW OF QUALITY CANADIAN CANNABIS STOCKS...

originally published Wednesday, May 24, 2017

Printable Version

All Marijuana stocks

A few days ago we reviewed a range of mostly US cannabis stocks, but it makes sense to also review the quality Canadian cannabis stocks at this time, for two reasons, because the quality Canadian stocks are on a more solid financial footing than some of their US counterparts – Canopy Growth is worth more than C$1 billion - and the Canadian cannabis industry is not blighted by being illegal at a federal level. Furthermore, these Canadian stocks trade in good volumes on US markets anyway, so are just as available to US investors as the US stocks.

Note that these two articles will be adjusted within a few days so that all the Canadian stocks will be together in this article.


Aphria Inc APH.TSX, APHQF on OTC, C$5.70, $4.22


Aphria Inc website


Aurora Cannabis Inc ACB.V, ACBFF on OTC, C$2.50, $1.86


Aurora Cannabis website


Canopy Growth Corp WEED.TSX, TWMJF on OTC, C$8.09, $5.97


Canopy Growth website


Organigram Holdings OGI.V, OGRMF on OTC, C$2.56, $1.92


Organigram Holdings website


End of report.


Posted at 7.30 am EDT on 24th May 17.

The above represents the opinion and analysis of Mr Maund, based on data available to him, at the time of writing. Mr. Maund's opinions are his own, and are not a recommendation or an offer to buy or sell securities. Mr. Maund is an independent analyst who receives no compensation of any kind from any groups, individuals or corporations mentioned in his reports. As trading and investing in any financial markets may involve serious risk of loss, Mr. Maund recommends that you consult with a qualified investment or securities advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction and do your own due diligence and research when making any kind of a transaction with financial ramifications. Although a qualified and experienced stock market technical analyst, Clive Maund is not a Registered Investment Advisor or Registered Securities Advisor. Therefore Mr. Maund's opinions on the market and stocks cannot be construed as a recommendation or solicitation to buy and sell securities.